[The companion diagnostics of targeted therapy and immunotherapy for hepatocellular carcinoma].

Huang, X W; Liu, S H; Zhao, J M

Huang, X W; Liu, S H; Zhao, J M.

Afiliación

Huang XW; Department of Pathology and Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Liu SH; Department of Pathology and Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Zhao JM; Department of Pathology and Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.

Zhonghua Gan Zang Bing Za Zhi ; 30(9): 912-917, 2022 Sep 20.

Article en Zh | MEDLINE | ID: mdl-36299182

Asunto(s)

Antineoplásicos; Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/patología; Neoplasias Hepáticas/patología; Inmunoterapia; Antineoplásicos/uso terapéutico; Terapia Molecular Dirigida

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Diagnostic_studies Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google